Palatin Technologies PTN
NASDAQ PTN
$5.11 -0.40 (-7.26%)
At close: Oct 23, 2026 · 4:00 PM EDT

Palatin Technologies (PTN) Price to Earnings (2017 - 2020)

Updated

Palatin Technologies' (PTN) Price to Earnings came in at 3244.22 for fiscal Q3 2020 (quarter ended Mar 31, 2020), down 46.6% from the prior quarter.

Analysis

Palatin Technologies (PTN) Price to Earnings (2017 - 2020) Analysis & Trends

For FY2019 (ended Jun 30, 2019), Palatin Technologies' Price to Earnings stood at 9193.58, down 6.6% from FY2018.

  • In prior fiscal years, Palatin Technologies' Price to Earnings was 9843.94 in FY2018 (+181.9%) and 3492.61 in FY2017.
  • The fiscal Q3 2020 figure stands as the lowest quarterly Price to Earnings in data going back to fiscal Q1 2018.
  • According to Business Quant data, Price to Earnings for the three prior fiscal quarters was 6079.75 (Q2 2020), 7008.86 (Q1 2020) and 9193.59 (Q4 2019).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn
10 Palatin Technologies 14.07 Mn -19.34 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2020 3,244.22
Dec 31, 2019 6,079.75
Sep 30, 2019 7,008.86
Jun 30, 2019 9,193.59
Jun 30, 2018 9.84 Mn
Mar 31, 2018 10.16 Mn
Dec 31, 2017 8.98 Mn
Sep 30, 2017 14.73 Mn
API Access

Palatin Technologies Price to Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-earnings&ticker=PTN&period=max&api_key=YOUR_API_KEY